Controlled release of peptide from biodegradable platforms for cardiovascular applications
Cenderitide, also known as CD-NP, is a designer peptide developed by Mayo Clinic for treating cardiovascular pathologies. CD-NP is synthesized by combining native mammalian c-type natriuretic peptide (CNP) and a C-terminus isolated from the dendroapis natriuretic peptide (DNP) of the venom of green...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
2013
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10356/55154 |